Skip to main content

Advertisement

SpringerLink
Log in

Pathogenesis of recurrent vulvovaginal candidiasis

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Recurrent vulvovaginal candidiasis (RVVC) is by no means uncommon and is a source of considerable physical suffering, in addition to serving as a major therapeutic challenge. The syndrome is multifactorial in etiology, hence management strategies must recognize the complex etiologic pathways. Considerable progress has been made in identifying secondary causes, including biologic and host factors. Specifically, Candida microbiologic studies have revealed that azole resistance in Candida albicans is rare and infection by less sensitive non-albicans Candida species is uncommon. At least half the women with RVVC have no identifiable host or microbial predisposing factors, and an immune-based hypothesis has been generated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Sobel JD: Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985, 152:924–935.

    PubMed  CAS  Google Scholar 

  2. Foxman B, Marsh JV, Gillespie B, et al.: Frequency and response to vaginal symptoms among white and black women: Results of a random digital dialing survey. J Women’s Health 1998, 7:1167–1174.

    CAS  Google Scholar 

  3. Sobel JD, Faro S, Force RW, et al.: Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998, 178:203–211.

    Article  PubMed  CAS  Google Scholar 

  4. Sobel JD, Kapernik P, Zervos M, et al.: Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001, 185:363–369. This large, prospective, randomized, controlled study served to validate the recommendation that severe and recurrent infections and those infections caused by non-albicans species should be considered complicated.

    Article  PubMed  CAS  Google Scholar 

  5. Giraldo P, von Nowaskonski A, Gomes FA, Linhares I, et al.: Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Obstet Gynecol 2000, 95:413–416.

    Article  PubMed  CAS  Google Scholar 

  6. Ohmit SE, Sobel JD, Schuman P, Duerr A, et al.: A longitudinal study of mucosal Candida colonization and candidiasis among HIV-seropositive and at-risk HIV-seronegative women. J Infect Dis 2002, In press.

  7. Vazquez JA, Sobel JD, Demitriou R, et al.: Karotyping of C. albicans obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis 1994, 170:1566–1569.

    PubMed  CAS  Google Scholar 

  8. Barousse MM, Steele C, Dunlap K, Espinosa T, et al.: Growth inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis 2001, 184:1489–1493.

    Article  PubMed  CAS  Google Scholar 

  9. Fidel PL Jr, Sobel JD: Host defense against vaginal candidiasis. In In Candida and Candidiasis, edn 1. Washington, DC: ASM Press; 2002:193–209 Comprehensive review of host defenses and mechanisms responsible for both prevention and exacerbation of Candida vaginitis.

    Google Scholar 

  10. Lynch ME, Sobel JD: Comparative in vitro activity of antimycotic against pathogenic vaginal yeast isolates. J Med Vet Mycol 1994, 32:267–274.

    PubMed  CAS  Google Scholar 

  11. DeLeon EM, Jacober SJ, Sobel JD, Foxman B: Prevalence and risk factors for vaginal Candida colonization in women with type I and II diabetes. BMC Infect Dis 2002, 2:1–11.

    Article  Google Scholar 

  12. Reed BD, Gorenflo DW, Gillespie BW, et al.: Sexual behavior as risk factors for Candida vulvovaginitis. J Womens Health Gend Med 2000, 9:645–655. Excellent review and delineation of sexual behavior that is responsible for some women acquiring RVVC.

    Article  CAS  Google Scholar 

  13. Sobel JD, Ohmit SE, Schuman P, et al.: The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered frorm HIV-seropositive and atrisk seronegative women. J Infect Dis 2001, 182:286–293.

    Google Scholar 

  14. Fong IW: The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole. Genitourin Med 1992, 68:174–176.

    PubMed  CAS  Google Scholar 

  15. Spinillo A, Carratta L, Pizzoli G, et al.: Recurrent vaginal candidiasis. Results of a cohort study of sexual transmission and intestinal reservoir. J Reprod Med 1992, 37:343–347.

    PubMed  CAS  Google Scholar 

  16. Chaim W, Foxman B, Sobel JD: Association of recurrent vaginal Candidiasis and secretary ABO and Lewis phenotype. J Infect Dis 1997, 176:828–830.

    Article  PubMed  CAS  Google Scholar 

  17. Ashman RB, Fulurija A, Papadimitriou JM: Strain-dependent differences - host response to Candida albicans infection in mice are related to organ susceptibility and infection load. Infect Immun 1996, 64:1866–1869.

    PubMed  CAS  Google Scholar 

  18. Hilton E, Isenberg HD, Alperstein P, et al.: Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992, 116:353–357.

    PubMed  CAS  Google Scholar 

  19. Sobel JD, Chaim W: Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol 1996, 34:2497–2502.

    PubMed  CAS  Google Scholar 

  20. Antonio MA, Hawes SE, Hillier SL: The identification of vaginal hactobacellus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999, 180:1950–1956.

    Article  PubMed  CAS  Google Scholar 

  21. Donders GGG, Renen H, Reybrouck R: Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Obstet Gynecol 2002, In press. Important contribution identifying yet another risk factor in nondiabetic women for recurrent infection.

  22. Fidel PL Jr, Sobel JD: Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996, 9:335–348.

    PubMed  Google Scholar 

  23. Picinni MP, Vultaggic A, Scaletti C, et al.: Type 1 T Helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis. J Infect Dis 2002, 186:87–93.

    Article  Google Scholar 

  24. Rosedale N, Braue K: Hyposensitization in the management of recurring vaginal candidiasis. Ann Allergy 1979, 43:250–253.

    PubMed  CAS  Google Scholar 

  25. Rigg D, Miller MM, Metzger WJ: Recurrent allergic vulvovaginitis treatment with Candida albicans sllergen immunotherapy. Am J Obstet Gynecol 1990, 162:332–339.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Harper University Hospital, 3990 John R - Room 4811, 48201, Detroit, MI, USA

    Jack D. Sobel MD

Authors
  1. Jack D. Sobel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sobel, J.D. Pathogenesis of recurrent vulvovaginal candidiasis. Curr Infect Dis Rep 4, 514–519 (2002). https://doi.org/10.1007/s11908-002-0038-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-002-0038-7

Keywords

Search

Navigation